Anzeige
Mehr »
Login
Donnerstag, 06.03.2025 Börsentäglich über 12.000 News von 689 internationalen Medien
Wie KI die Medikamentenzulassung um Jahre verkürzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 913004 | ISIN: US7599101026 | Ticker-Symbol:
NASDAQ
05.03.25
21:59 Uhr
3,210 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
KORU MEDICAL SYSTEMS INC Chart 1 Jahr
5-Tage-Chart
KORU MEDICAL SYSTEMS INC 5-Tage-Chart

Aktuelle News zur KORU MEDICAL SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.02.Piper Sandler cuts Koru Medical stock rating to neutral1
KORU MEDICAL SYSTEMS Aktie jetzt für 0€ handeln
07.02.KORU Medical Systems signs agreement for subcutaneous immunoglobulin infusion system2
30.01.KORU Medical kooperiert für Phase-III-Studie bei seltener Nierenerkrankung1
30.01.KORU Medical partners for Phase III trial in rare kidney disorder1
17.01.Analyst Expectations For KORU Medical Systems' Future3
13.01.KORU Medical Systems reports record Q4 and FY24 revenue1
13.01.KORU Medical reports 23% Q4 revenue growth1
13.01.KORU Medical verzeichnet 23% Umsatzwachstum im vierten Quartal1
13.01.KORU Medical Systems, Inc. - 8-K, Current Report-
13.01.KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter54MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization...
► Artikel lesen
13.11.24KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance70MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization...
► Artikel lesen
13.11.24KORU Medical Systems, Inc. - 10-Q, Quarterly Report-
13.11.24KORU Medical Systems, Inc. - 8-K, Current Report-
07.08.24KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance92MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization...
► Artikel lesen
05.06.24Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion677The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System") and SCHOTT Pharma, manufacturer of SCHOTT TOPPAC prefillable polymer...
► Artikel lesen
01.05.24KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth119MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization...
► Artikel lesen
11.04.24KORU Medical Systems, Inc.: KORU Medical Systems Announces Successful Appeal in EU Notified Body Review447KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric...
► Artikel lesen
13.03.24KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance173MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1